Literature DB >> 21091028

Surviving chemotherapy for colon cancer and living with the consequences.

Cindy Tofthagen1.   

Abstract

BACKGROUND: This article discusses peripheral neuropathy as a long-term side effect of oxaliplatin based chemotherapy, from a colon cancer survivor's perspective. Peripheral neuropathy is a common side effect of chemotherapy that affects quality of life for many cancer survivors. Severe and debilitating neuropathy negatively impacts both physical and emotional well-being. DISCUSSION: A better understanding of what cancer survivors with peripheral neuropathy experience is essential for health care professionals. More emphasis on symptom management and development of evidence based interventions will help improve quality of life for those who are affected by chemotherapy induced peripheral neuropathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21091028     DOI: 10.1089/jpm.2010.0124

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  30 in total

Review 1.  The Physical Consequences of Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Cindy S Tofthagen; Andrea L Cheville; Charles L Loprinzi
Journal:  Curr Oncol Rep       Date:  2020-04-22       Impact factor: 5.075

Review 2.  Emerging trends in understanding chemotherapy-induced peripheral neuropathy.

Authors:  Jérémy Ferrier; Vanessa Pereira; Jérome Busserolles; Nicolas Authier; David Balayssac
Journal:  Curr Pain Headache Rep       Date:  2013-10

3.  Neuropathic symptoms, quality of life, and clinician perception of patient care in medical oncology outpatients with colorectal, breast, lung, and prostate cancer.

Authors:  Desiree Jones; Fengmin Zhao; Joanna Brell; Mark A Lewis; Charles L Loprinzi; Matthias Weiss; Michael J Fisch
Journal:  J Cancer Surviv       Date:  2014-07-15       Impact factor: 4.442

4.  Impact of oxaliplatin-induced neuropathy: a patient perspective.

Authors:  Barbara K Bennett; Susanna B Park; Cindy S-Y Lin; Michael L Friedlander; Matthew C Kiernan; David Goldstein
Journal:  Support Care Cancer       Date:  2012-03-17       Impact factor: 3.603

5.  Chemotherapy-induced peripheral neuropathy-patient-reported outcomes compared with NCI-CTCAE grade.

Authors:  Aaron C Tan; J Matt McCrary; Susanna B Park; Terry Trinh; David Goldstein
Journal:  Support Care Cancer       Date:  2019-04-10       Impact factor: 3.603

6.  Chemotherapy-related neuropathic symptom management: a randomized trial of an automated symptom-monitoring system paired with nurse practitioner follow-up.

Authors:  Noah Allan Kolb; Albert Gordon Smith; John Robinson Singleton; Susan L Beck; Diantha Howard; Kim Dittus; Summer Karafiath; Kathi Mooney
Journal:  Support Care Cancer       Date:  2017-12-05       Impact factor: 3.603

7.  Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.

Authors:  Ellen M Lavoie Smith; Herbert Pang; Constance Cirrincione; Stewart Fleishman; Electra D Paskett; Tim Ahles; Linda R Bressler; Camilo E Fadul; Chetaye Knox; Nguyet Le-Lindqwister; Paul B Gilman; Charles L Shapiro
Journal:  JAMA       Date:  2013-04-03       Impact factor: 56.272

8.  The Experience of Chemotherapy-Induced Peripheral Neuropathy Among Childhood Cancer Survivors.

Authors:  Caroline Mohrmann
Journal:  J Pediatr Oncol Nurs       Date:  2019-05-05       Impact factor: 1.636

Review 9.  Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Grace A Kanzawa-Lee; Robert Knoerl; Clare Donohoe; Celia M Bridges; Ellen M Lavoie Smith
Journal:  Semin Oncol Nurs       Date:  2019-04-30       Impact factor: 2.315

10.  Chemotherapy-induced peripheral neuropathy: an algorithm to guide nursing management.

Authors:  Cindy Tofthagen; Constance M Visovsky; Rachelle Hopgood
Journal:  Clin J Oncol Nurs       Date:  2013-04       Impact factor: 1.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.